Neogen Corporation (NEOG)

Market Cap	2.76B
Revenue (ttm)	912.20M
Net Income (ttm)	-23.53M
Shares Out	216.70M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	24.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,891,527
Open	12.32
Previous Close	12.25
Day's Range	12.27 - 12.85
52-Week Range	11.46 - 19.88
Beta	1.23
Analysts	Buy
Price Target	16.25 (+27.65%)
Earnings Date	Jan 9, 2025

About NEOG

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residue...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 23, 1989
• Employees: 2,917
• Stock Exchange: NASDAQ
• Ticker Symbol: NEOG
• Website: https://www.neogen.com

Financial Performance

In 2024, Neogen's revenue was $924.22 million, an increase of 12.37% compared to the previous year's $822.45 million. Losses were -$9.42 million, -58.81% less than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price forecast is $16.25, which is an increase of 27.65% from the latest price.

Price Target

$16.25

(27.65% upside)

Analyst Consensus: Buy